Tofacitinib in pyoderma gangrenosum–A case series
VA Sathyanarayana, D Roy… - … Journal of Rheumatic …, 2024 - Wiley Online Library
Pyoderma gangrenosum (PG) is a rare autoinflammatory disorder falling under the spectrum
of neutrophilic dermatosis, characterized by distinctive skin ulceration which is non‐infective …
of neutrophilic dermatosis, characterized by distinctive skin ulceration which is non‐infective …
Recalcitrant Pyoderma Gangrenosum: Clinical Burden and Unmet Needs
SL Becker, R Velasco… - Clinical, Cosmetic and …, 2023 - Taylor & Francis
Pyoderma gangrenosum (PG) is a rare, autoinflammatory disease leading to aseptic ulcers
which carries a significant disease burden and is often difficult to treat, with many patients …
which carries a significant disease burden and is often difficult to treat, with many patients …
Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patients
G Caldarola, DO Traini, GM Falco… - International Journal …, 2024 - Wiley Online Library
Background Over the past few decades, advances in medical research and diagnostic tools
have shed light on some aspects of pyoderma gangrenosum (PG). Nevertheless, the …
have shed light on some aspects of pyoderma gangrenosum (PG). Nevertheless, the …
[HTML][HTML] Narrative Review: Pyoderma Gangrenosum
AN Park, A Raj, J Bajda, VR Gorantla - Cureus, 2024 - ncbi.nlm.nih.gov
Pyoderma gangrenosum (PG) is a skin lesion, characteristically a neutrophilic dermatosis,
that can be complicated by rapid progression, necrosis, and ulceration. This is an important …
that can be complicated by rapid progression, necrosis, and ulceration. This is an important …
A rare case study of pyoderma gangrenosum with dilated cardiomyopathy and multiple cerebral infarct in malnourished children
R Adrizain, P Rayani, P Hapsari, V Indriasari… - Heliyon, 2024 - cell.com
Pyoderma gangrenosum (PG) is an extremely rare case of sterile necrotic ulcerative disease
associated with malnutrition as a predisposition factor. It is unclear, though, whether dilated …
associated with malnutrition as a predisposition factor. It is unclear, though, whether dilated …
[HTML][HTML] Analysis of clinical characteristics and factors affecting treatment responses in patients with pyoderma gangrenosum: a multicenter study of 239 patients☆
F Erduran, E Adışen, Y Hayran, GG Aksoy… - Anais Brasileiros de …, 2024 - Elsevier
Abstract Background Pyoderma Gangrenosum (PG) is a chronic disease characterized by
recalcitrant skin ulcers. Objective We aimed to evaluate the demographic, clinical …
recalcitrant skin ulcers. Objective We aimed to evaluate the demographic, clinical …
Genetic findings in a patient with paradoxical pyoderma gangrenosum induced by brodalumab
IF Aromolo, CA Maronese, C Moltrasio… - Clinical and …, 2023 - academic.oup.com
We describe a patient with psoriasis who developed pyoderma gangrenosum while on
treatment with brodalumab, an anti-interleukin (IL)-17 receptor monoclonal antibody …
treatment with brodalumab, an anti-interleukin (IL)-17 receptor monoclonal antibody …
The role of interleukins 6, 8, 17 and 23 in the pathogenesis of pyoderma gangrenosum.
K Rubas, A Reich… - Journal of the …, 2023 - search.ebscohost.com
Forty-eight PG patients were included in the study on the basis of achieving the
PARACELSUS score of >= 10.[4] Patients receiving systemic treatment for PG were …
PARACELSUS score of >= 10.[4] Patients receiving systemic treatment for PG were …
Certolizumab treatment of localized pyoderma gangrenosum in a pregnant patient
N Wang, C Yu, W Wang, Q Yang - Journal of Dermatological …, 2023 - Taylor & Francis
The purpose of the article Pyoderma gangrenosum (PG) is an ulcerating neutrophilic
dermatosis with an incidence of 3-10 patients per million. PG equally affects patients of both …
dermatosis with an incidence of 3-10 patients per million. PG equally affects patients of both …
[HTML][HTML] Adjunctive Hyperbaric Oxygen Treatment for Challenging Pyoderma Gangrenosum Cases
EL Hodson, A Kranyak, I Salem, JC Buckey Jr - Journal of Tissue Viability, 2024 - Elsevier
Introduction Pyoderma gangrenosum (PG) is a rare, difficult-to-treat neutrophilic ulcerative
cutaneous condition that severely impacts those affected. Treatment options for PG are …
cutaneous condition that severely impacts those affected. Treatment options for PG are …